We are appreciative of the generous supports from the above Federal and private institutes, and industrial partners.

Only active grants are listed here. For a complete list of both active and completed grants, click here.

• 2/2020 - 1/2023
  

  Neuroinflammation-related phosphoprotein signaling pathways as potential therapeutic targets for GWI using an established animal model.

  DOD
  Role: PI
  
• 9/2020 - 4/2025

  Extracellular Vesicle treatment and age-related neuropathology in non-human primates.

  NIH
  Role: Sub-PI
  
• 9/2019 - 7/2023

  Multiplex mass spectrometric protein assays for precise monitoring of the pathophysiology of obesity.

  NIH
  Role: Sub-PI
  
• 9/2019 - 9/2023

  The Network Biology of Pathogen-Host Interactions Driving Exacerbation in Chronic Obstructive Pulmonary Disease.

  DOD
  Role: PI
  
• 9/2019 - 8/2023

  A 3D-printed micro-scaffold for MS Imaging and Spatially Resolved Determination of Mab and Receptors in Tissues.

  Center for Protein Therapeutics (CPT)
  Role: PI
  
• 5/2018 – 4/2023
  

  GMPS-GMPR Axis Melanoma Progression and Therapy

  NIH
  Role: Sub-PI
  
• 9/2021 - 11/2026

  Ribosome Heterogeneity in Cryptococcus neoformans.

  NIH
  Role: Co-I
  
• 2/2022 - 1/2026

  System Biology for Glycosylation.

  NIH
  Role: Co-I
  
• 5/2021 - 4/2025

  Elucidating the role of protein arginine methylation in regulating RNA-binding protein function.

  NSF
  Role: Co-I
  
• 7/2020 - 6/2023

  Role of ceramide kinase and ceramide-1-phosphate in endocrine resistant breast cancer.

  DOD
  Role: Co-I
  
• 12/2018 - 11/2023

  Salivary Protein Influence on Taste and Feeding.

  NIH
  Role: Co-I
  
• 9/2018 - 8/2023

  The role of oral spirochete virulence factors in the impairment of neutrophil responses.

  NIH
  Role: Co-I